Evidence map›Paper›PMID 23504804›Full record

ArticleThe Journal of comparative neurology2013

Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: implications for mesolimbic dopamine transmission.

Miguel Garzón, Virginia M Pickel

Open access · greenAbstract read
In one paragraph

Article in The Journal of comparative neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Miguel GarzónDepartment of Anatomy, Histology, and Neuroscience, Medical School, Universidad Autónoma de Madrid (UAM), Madrid, 28029, Spain. miguel.garzon@uam.es
Virginia M Pickel
MIND Research Institute · US

Funding

ULTRASTUCTURE, RECEPTORS, AND GENE EXPRESSIONP60DA005130 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 2002 to 2012
$30.6M
Radiotelemetry CoreP01HL096571 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ANRATHER, JOSEF · 2009 to 2013
$8.8M
UNIQUE RNA STRUCTURE OF CAUSATIVE AGENT FOR DELTA HEPATITISP50DA005130 · NIDA · ROCKEFELLER UNIVERSITY · PI YU, JUN · 1987 to 2001
$5.0M
EM-TRANSMITTER INTERACTIONS OF STRIATAL OPIOID NEURONSR01DA004600 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI PICKEL, VIRGINIA M · 1989 to 2013
$3.1M
ULTRASTRUCTURE OF MESOLIMBIC TRANSMITTER INTERACTIONSR37MH040342 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI PICKEL, VIRGINIA M · 1988 to 2007
$2.5M
ULTRASTRUCTURE OF MESOLIMBIC TRANSMITTER INTERACTIONSR01MH040342 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI PICKEL, VIRGINIA M · 1985 to 2012
$1.7M
ICAM-1 AND BETA 2 INTEGRINS IN ANTIGEN INDUCED ASTHMAF32HL009657 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LU, HUIFANG · 1997 to 1999
–
NHLBI NIH HHS F32 HL009657NHLBI NIH HHS HL09657NHLBI NIH HHS P01 HL096571NIDA NIH HHS DA005130NIDA NIH HHS DA04600NIDA NIH HHS P50 DA005130NIDA NIH HHS P60 DA005130NIDA NIH HHS R01 DA004600NIMH NIH HHS MH40342NIMH NIH HHS R01 MH040342NIMH NIH HHS R37 MH040342
6 · The paper itself

Abstract

Muscarinic modulation of mesolimbic dopaminergic neurons in the ventral tegmental area (VTA) plays an important role in reward, potentially mediated through the M5 muscarinic acetylcholine receptor (M5R). However, the key sites for M5R-mediated control of dopamine neurons within this region are still unknown. To address this question we examined the electron microscopic immunocytochemical localization of antipeptide antisera against M5R and the plasmalemmal dopamine transporter (DAT) in single sections through the rat VTA. M5R was located mainly to VTA somatodendritic profiles (71%; n = 627), at least one-third (33.2%; n = 208) of which also contained DAT. The M5R immunoreactivity was distributed along cytoplasmic tubulovesicular endomembrane systems in somata and large dendrites, but was more often located at plasmalemmal sites in small dendrites, the majority of which did not express DAT. The M5R-immunoreactive dendrites received a balanced input from unlabeled terminals forming either asymmetric or symmetric synapses. Compared with dendrites, M5R was less often seen in axon terminals, comprising only 10.8% (n = 102) of the total M5R-labeled profiles. These terminals were usually presynaptic to unlabeled dendrites, suggesting that M5R activation can indirectly modulate non-DAT-containing dendrites through presynaptic mechanisms. Our results provide the first ultrastructural evidence that in the VTA, M5R has a subcellular location conducive to major involvement in postsynaptic signaling in many dendrites, only some of which express DAT. These findings suggest that cognitive and rewarding effects ascribed to muscarinic activation in the VTA can primarily be credited to M5R activation at postsynaptic plasma membranes distinct from dopamine transport.

Indexed as

Analysis of VarianceAnimalsDendritesDopamineDopamine Plasma Membrane Transport ProteinsMaleMiceMice, Inbred C57BLMicroscopy, ElectronMicroscopy, ImmunoelectronNeurogliaNeuronsPresynaptic TerminalsRatsRats, Sprague-DawleyReceptor, Muscarinic M5DopamineDopamine Plasma Membrane Transport ProteinsReceptor, Muscarinic M5acetylcholinemotivationreinforcementrewardultrastructure

Identifiers

PMID23504804
PMCPMC4038040
OpenAlexW1840235966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.